摘要
目的观察地尔硫卓对冠心病行介入治疗术后患者心绞痛的影响。方法选择我院2012年8月-2015年7月收治的并行介入治疗术的冠心病患者86例,随机分为观察组和对照组,每组43例,对照组采用术后常规治疗方法,观察组在对照组的基础上加用地尔硫卓片治疗。结果与对照组比较,观察组治疗后心绞痛发生次数降低更加显著,差异有统计学意义（P〈0.05）。结论地尔硫卓可以减少冠心病行介入治疗术后患者心绞痛发生次数。
Objective To observe the effect of diltiazem in patients with angina pectoris of coronary heart disease for postoperative treatment. Methods 86 cases of coronary heart disease with coronary heart disease in our hospital from August 2012 to July 2015 were selected,randomly divided into observation group and control group,each group of 43 cases,the control group was treated with routine treatment,the observation group in the control group treated with diltiazem tablets in the treatment.Results Compared with the control group,in the observation group,the incidence of angina pectoris was more significant,the difference was statistically significant（P〈0.05）. Conclusion Diltiazem can reduce coronary heart disease after interventional therapy for patients with angina frequency.
出处
《中国卫生标准管理》
2016年第1期88-89,共2页
China Health Standard Management
关键词
地尔硫卓
冠心病
介入治疗
心绞痛
Diltiazem
Coronary heart disease（CHD）
Interventional therapy
Angina pectoris
